INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 155 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,385,665 | +208.4% | 84,194 | +220.6% | 0.01% | +83.3% |
| Q1 2023 | $1,421,979 | +75.6% | 26,260 | +50.8% | 0.01% | +50.0% |
| Q3 2022 | $810,000 | +166.4% | 17,410 | +199.4% | 0.00% | +300.0% |
| Q4 2021 | $304,000 | -9.3% | 5,815 | -29.1% | 0.00% | 0.0% |
| Q2 2021 | $335,000 | -1.8% | 8,198 | -23.6% | 0.00% | -66.7% |
| Q4 2020 | $341,000 | -70.1% | 10,728 | -75.9% | 0.00% | -80.0% |
| Q3 2020 | $1,141,000 | +513.4% | 44,474 | +266.5% | 0.02% | +200.0% |
| Q1 2020 | $186,000 | -83.1% | 12,134 | -91.8% | 0.01% | -50.0% |
| Q3 2019 | $1,100,000 | +58.3% | 147,257 | +175.0% | 0.01% | +42.9% |
| Q2 2019 | $695,000 | +44.2% | 53,545 | +35.3% | 0.01% | +40.0% |
| Q1 2019 | $482,000 | +66.8% | 39,569 | +56.0% | 0.01% | +66.7% |
| Q4 2018 | $289,000 | -45.8% | 25,366 | +3.3% | 0.00% | -50.0% |
| Q3 2018 | $533,000 | -25.5% | 24,567 | -39.3% | 0.01% | -33.3% |
| Q2 2018 | $715,000 | -25.2% | 40,466 | -10.9% | 0.01% | -40.0% |
| Q1 2018 | $956,000 | +267.7% | 45,400 | +175.1% | 0.02% | +200.0% |
| Q3 2017 | $260,000 | -15.0% | 16,505 | -18.6% | 0.01% | -61.5% |
| Q4 2016 | $306,000 | +84.3% | 20,270 | +86.6% | 0.01% | +18.2% |
| Q3 2016 | $166,000 | -56.0% | 10,863 | +55.2% | 0.01% | -73.2% |
| Q4 2015 | $377,000 | – | 7,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |